Laparoscopic surgery and robotic surgery for hilar cholangiocarcinoma: an updated systematic review.
hilar cholangiocarcinoma
minimally invasive surgery
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
24
02
2020
revised:
13
04
2020
accepted:
19
04
2020
pubmed:
13
5
2020
medline:
15
5
2021
entrez:
13
5
2020
Statut:
ppublish
Résumé
The role of laparoscopic surgery (Lap) and robotic surgery (Rob) for radical resection of hilar cholangiocarcinoma (HC) is not clear. We summarized the safety and feasibility of Lap and Rob for HC. A search of all HC studies in English published on PubMed up to April 2020 was conducted. References from retrieved articles were reviewed to broaden the search. In total, 23 reports were enrolled: 15 involving Lap, seven using Rob and one study reporting a minimally invasive approach (Lap or Rob, not specified). A total of 205 cases of HC were documented (Lap/Rob/not specified, 99/101/5): 37 cases of Bismuth type-I (Lap/Rob, 17/20), 22 cases of Bismuth type-II (Lap/Rob, 15/7), 68 cases of type-III (Lap/Rob, 39/29) and 13 cases of type-IV (Lap/Rob, 9/4). The pooled prevalence of R0 resection was 80.1% (Lap/Rob, 85.9%/71.0%). The weighted mean for operative time, blood loss and post-operative hospital stay was 458.4 min (Lap/Rob, 423.3/660.8 min), 615.3 mL (Lap/Rob, 521.0/1188.5 mL) and 14.0 days (Lap/Rob, 14.0/13.7 days), respectively. The pooled prevalence of conversion to open surgery, post-operative complications, and perioperative mortality was 9.1% (Lap/Rob, 12.2%/3.8%), 47.2% (Lap/Rob, 38.4%/61.3%) and 3.0% (Lap/Rob, 4.0%/2.0%), respectively. With innovations in technology and gradual accumulation of surgical experience, the feasibility and safety of performing Lap and Rob for HC will improve.
Sections du résumé
BACKGROUND
The role of laparoscopic surgery (Lap) and robotic surgery (Rob) for radical resection of hilar cholangiocarcinoma (HC) is not clear. We summarized the safety and feasibility of Lap and Rob for HC.
METHODS
A search of all HC studies in English published on PubMed up to April 2020 was conducted. References from retrieved articles were reviewed to broaden the search.
RESULTS
In total, 23 reports were enrolled: 15 involving Lap, seven using Rob and one study reporting a minimally invasive approach (Lap or Rob, not specified). A total of 205 cases of HC were documented (Lap/Rob/not specified, 99/101/5): 37 cases of Bismuth type-I (Lap/Rob, 17/20), 22 cases of Bismuth type-II (Lap/Rob, 15/7), 68 cases of type-III (Lap/Rob, 39/29) and 13 cases of type-IV (Lap/Rob, 9/4). The pooled prevalence of R0 resection was 80.1% (Lap/Rob, 85.9%/71.0%). The weighted mean for operative time, blood loss and post-operative hospital stay was 458.4 min (Lap/Rob, 423.3/660.8 min), 615.3 mL (Lap/Rob, 521.0/1188.5 mL) and 14.0 days (Lap/Rob, 14.0/13.7 days), respectively. The pooled prevalence of conversion to open surgery, post-operative complications, and perioperative mortality was 9.1% (Lap/Rob, 12.2%/3.8%), 47.2% (Lap/Rob, 38.4%/61.3%) and 3.0% (Lap/Rob, 4.0%/2.0%), respectively.
CONCLUSION
With innovations in technology and gradual accumulation of surgical experience, the feasibility and safety of performing Lap and Rob for HC will improve.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
42-48Informations de copyright
© 2020 Royal Australasian College of Surgeons.
Références
Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet 2014; 383: 2168-79.
Banales JM, Cardinale V, Carpino G et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 2016; 13: 261-80.
Blechacz B. Cholangiocarcinoma: current knowledge and new developments. Gut Liver 2017; 11: 13-26.
Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17: 691-9.
Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int. J. Colorectal Dis. 2015; 30: 159-71.
Neuhaus P, Jonas S, Bechstein WO et al. Extended resections for hilar cholangiocarcinoma. Ann. Surg. 1999; 230: 808-19.
Jarnagin WR, Fong Y, DeMatteo RP et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 2001; 234: 507-19.
Ciria R, Cherqui D, Geller DA, Briceno J, Wakabayashi G. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann. Surg. 2016; 263: 761-77.
Ocuin LM, Tsung A. Robotic liver resection for malignancy: current status, oncologic outcomes, comparison to laparoscopy, and future applications. J. Surg. Oncol. 2015; 112: 295-301.
Lim C, Salloum C, Tudisco A et al. Short- and long-term outcomes after robotic and laparoscopic liver resection for malignancies: a propensity score-matched study. World J. Surg. 2019; 43: 1594-603.
Giulianotti PC, Sbrana F, Bianco FM, Addeo P. Robot-assisted laparoscopic extended right hepatectomy with biliary reconstruction. J. Laparoendosc. Adv. Surg. Tech. A 2010; 20: 159-63.
Yu H, Wu SD, Chen DX, Zhu G. Laparoscopic resection of Bismuth type I and II hilar cholangiocarcinoma: an audit of 14 cases from two institutions. Dig. Surg. 2011; 28: 44-9.
Liu QD, Chen JZ, Xu XY, Zhang T, Zhou NX. Incidence of port-site metastasis after undergoing robotic surgery for biliary malignancies. World J. Gastroenterol. 2012; 18: 5695-701.
Machado MA, Makdissi FF, Surjan RC, Mochizuki M. Laparoscopic resection of hilar cholangiocarcinoma. J. Laparoendosc. Adv. Surg. Tech. A 2012; 22: 954-6.
Gumbs AA, Jarufe N, Gayet B. Minimally invasive approaches to extrapancreatic cholangiocarcinoma. Surg. Endosc. 2013; 27: 406-14.
Yu H, Wu SD, Tian Y, Su Y, Li YN. Single-incision laparoscopic resection of Bismuth I hilar cholangiocarcinoma. Surg. Innov. 2013; 20: 209-13.
Cho A, Yamamoto H, Kainuma O et al. Laparoscopy in the management of hilar cholangiocarcinoma. World J. Gastroenterol. 2014; 20: 15153-7.
Lin E, Sarmiento JM. Laparoscopic extended right hepatectomy, portal lymphadenectomy, and hepaticojejunostomy for hilar cholangiocarcinoma. J. Laparoendosc. Adv. Surg. Tech. A 2014; 24: 411-6.
Zhu Z, Liu Q, Chen J et al. Robotic surgery twice performed in the treatment of hilar cholangiocarcinoma with deep jaundice: delayed right hemihepatectomy following the right-hepatic vascular control. Surg. Laparosc. Endosc. Percutan. Tech. 2014; 24: e184-90.
Lee W, Han HS, Yoon YS et al. Laparoscopic resection of hilar cholangiocarcinoma. Ann. Surg. Treat. Res. 2015; 89: 228-32.
Puntambekar S, Sharma V, Kumar S, Mitkare S, Joshi G, Parikh H. Laparoscopic management of hilar cholangiocarcinoma: a case report. Indian J. Surg. 2016; 78: 57-9.
Quijano Y, Vicente E, Ielpo B et al. Robotic liver surgery: early experience from a single surgical center. Surg. Laparosc. Endosc. Percutan. Tech. 2016; 26: 66-71.
Xu Y, Wang H, Ji W et al. Robotic radical resection for hilar cholangiocarcinoma: perioperative and long-term outcomes of an initial series. Surg. Endosc. 2016; 30: 3060-70.
Li J, Zhao L, Zhang J et al. Application of the laparoscopic technique in perihilar cholangiocarcinoma surgery. Int. J. Surg. 2017; 44: 104-9.
Zhang CW, Liu J, Hong DF et al. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma. Surg. Endosc. 2018; 32: 1581-2.
Chong EH, Choi SH. Hybrid laparoscopic and robotic hepatopancreaticoduodenectomy for cholangiocarcinoma. J. Gastrointest. Surg. 2019; 23: 1947-8.
Elmoghazy W, Cowan J, Tabchouri N et al. Liver resection for extra-pancreatic biliary cancer: what is the role of laparoscopic approach? Surg. Endosc. 2019; 33: 3711-7.
Feng F, Cao X, Liu X et al. Laparoscopic resection for Bismuth type III and IV hilar cholangiocarcinoma: how to improve the radicality without direct palpation. J. Surg. Oncol. 2019; 120: 1379-85.
Zhang Y, Dou C, Wu W et al. Total laparoscopic versus open radical resection for hilar cholangiocarcinoma. Surg. Endosc. 2019. https://doi.org/10.1007/s00464-019-07211-0.
Li J, Tan X, Zhang X et al. Robotic radical surgery for hilar cholangiocarcinoma: a single-Centre case series. Int. J. Med. Robot. 2020. https://doi.org/10.1002/rcs.2076.
Liu S, Liu X, Li X et al. Application of laparoscopic radical resection for type III and IV hilar cholangiocarcinoma treatment. Gastroenterol. Res. Pract. 2020; 2020: 1506275.
Ratti F, Fiorentini G, Cipriani F et al. Perihilar cholangiocarcinoma: are we ready to step towards minimally invasiveness? Updates Surg. 2020. https://doi.org/10.1007/s13304-020-00752-3.
Chin KM, Chua DWQ, Lee SY et al. Outcome of minimally invasive liver resection for extrapancreatic biliary malignancies: a single-institutional experience. J. Minim. Access Surg. 2020. https://doi.org/10.4103/jmas.JMAS_247_19.
Boggi U, Amorese G, Vistoli F et al. Laparoscopic pancreaticoduodenectomy: a systematic literature review. Surg. Endosc. 2015; 29: 9-23.
Ding J, Zhang C, Huang D, Zhang Y. The state of minimally invasive pancreaticoduodenectomy in Chinese mainland: a systematic literature review. Biosci. Trends 2020; 13: 488-501.
Hu HJ, Wu ZR, Jin YW et al. Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives. ANZ J. Surg. 2019; 89: 476-80.
Franken LC, van der Poel MJ, Latenstein AEJ et al. Minimally invasive surgery for perihilar cholangiocarcinoma: a systematic review. J. Robot. Surg. 2019; 13: 717-27.
Goh BKP, Prieto M, Syn N et al. Critical appraisal of the learning curve of minimally invasive hepatectomy: experience with the first 200 cases of a Southeast Asian early adopter. ANZ J. Surg. 2020. https://doi.org/10.1111/ans.15683.
Hakeem AR, Marangoni G, Chapman SJ et al. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur. J. Gastroenterol. Hepatol. 2014; 26: 1047-54.
Ma WJ, Wu ZR, Hu HJ et al. Extended lymphadenectomy versus regional lymphadenectomy in resectable hilar cholangiocarcinoma. J. Gastrointest. Surg. 2019. https://doi.org/10.1007/s11605-019-04244-7.
Kitagawa Y, Nagino M, Kamiya J et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann. Surg. 2001; 233: 385-92.
Birgin E, Rasbach E, Reissfelder C et al. A systematic review and meta-analysis of caudate lobectomy for treatment of hilar cholangiocarcinoma. Eur. J. Surg. Oncol. 2020. https://doi.org/10.1016/j.ejso.2020.01.023.
van Gulik TM, Ruys AT, Busch OR et al. Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough? Dig. Surg. 2011; 28: 141-7.
Han IW, Jang JY, Kang MJ et al. Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection. Ann. Surg. Treat. Res. 2014; 87: 87-93.
Shimizu H, Kimura F, Yoshidome H et al. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann. Surg. 2010; 251: 281-6.
Paik KY, Choi DW, Chung JC, Kang KT, Kim SB. Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J. Gastrointest. Surg. 2008; 12: 1268-74.
Sano T, Shimada K, Sakamoto Y, Esaki M, Kosuge T. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J. Hepatobiliary Pancreat. Surg. 2007; 14: 455-62.
Okabe H, Beppu T, Ishiko T et al. Preoperative portal vein embolization (PVE)for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival. J. Surg. Oncol. 2011; 104: 641-6.